EP1220802B1 — Device housing for an aerosol container
Assigned to Glaxo Group Ltd · Expires 2004-02-18 · 22y expired
What this patent protects
An assembly having: a container configured to contain a product, the container having an end having a dispensing end surface, a central axis which extends through the end, and a neck underneath the end, the neck having an outer surface which tapers outwardly away from the central…
USPTO Abstract
An assembly having: a container configured to contain a product, the container having an end having a dispensing end surface, a central axis which extends through the end, and a neck underneath the end, the neck having an outer surface which tapers outwardly away from the central axis as it extends in a direction towards the end; an accessory non-removably mounted on the end of the container, the accessory having a surface bearing against the dispensing end surface of the container, and a sleeve disposed about the neck so that an inner surface of the sleeve is in facing relation with the neck outer surface, and; an annular collar wedged between the sleeve inner surface and the neck outer surface and joined to the sleeve inner surface by a permanent joint.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.